Zhejiang Jianfeng Group Co., Ltd. engages in the building materials and pharmaceuticals business in China. The company offers pharmaceutical products, including antibiotics, cardiovascular drugs, antidepressants, ophthalmic drugs, anti-tumor drugs, and infant medications. It is involved in investment in pharmaceutical and healthcare industries; manufacturing and sales of cement and cement concrete; production and sales of pharmaceutical intermediates; sales of pharmaceutical chemical raw materials; and import and export business; and other industrial investments. Zhejiang Jianfeng Group Co., Ltd. was incorporated in 1989 and is based in Jinhua, China.
Research context
Zhejiang Jianfeng Group Co., Ltd appears in PyInvesting’s Shanghai Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- CNY
- Sector
- Basic Materials
- Industry
- Building Materials
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Zhejiang Jianfeng Group Co., Ltd is currently in a long term downtrend where the price is trading 12.5% below its 200 day moving average.
From a valuation standpoint, the stock is 62.6% cheaper than other stocks from the Basic Materials sector with a price to sales ratio of 1.5.
Zhejiang Jianfeng Group Co., Ltd's total revenue sank by 9.3% to $800M since the same quarter in the previous year.
Its net income has increased by 6.6% to $148M since the same quarter in the previous year.
Finally, its free cash flow fell by 303.8% to $-42M since the same quarter in the previous year.
Based on the above factors, Zhejiang Jianfeng Group Co., Ltd gets an overall score of 2/5.